rapibloc 20 mg/2 ml
aop orphan pharmaceuticals ag - austria - landiololum - conc. pt. sol. inj. - 20mg/2ml - agenti betablocanti betablocante selective
voriconazol sandoz 200 mg
lek pharmaceuticals d.d. - slovenia - voriconazolum - pulb. pt. sol. perf. - 200 mg - antimicotice de uz sistemic derivati de triazol
rapibloc 20 mg/2 ml
aop orphan pharmaceuticals gmbh - austria - landiololum - conc. pt. sol. inj. - 20mg/2ml - agenti betablocanti betablocante selective
rapibloc 300 mg
aop orphan pharmaceuticals ag - austria - landiololum - pulb. pt. sol. perf. - 300mg - agenti betablocanti betablocante selective
rapibloc 300 mg
aop orphan pharmaceuticals gmbh - austria - landiololum - pulb. pt. sol. perf. - 300mg - agenti betablocanti betablocante selective
gemcirena 38 mg/ml
fresenius kabi deutschland gmbh - germania - gemcitabinum - pulb. pt. sol. perf. - 38mg/ml - antimetaboliti analogi ai bazelor pirimidinice
varromed
beevital gmbh - oxalic acid de sodiu dihidrat, acid formic - ectoparasiticides pentru uz topic, incl. insecticide - albinele - tratamentul varroozelor (varroa destructor) în coloniile de albine cu și fără puiet.
takhzyro
takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedem, ereditar - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.
orladeyo
biocryst ireland limited - berotralstat dihydrochloride - angioedem, ereditar - other hematological agents - orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in adult and adolescent patients aged 12 years and older.
icatibant accord
accord healthcare s.l.u. - icatibant acetate - angioedem, ereditar - other hematological agents - icatibant accord is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older, with c1 esterase inhibitor deficiency.